Thesis for doctoral degree (Ph.D.) 2007 Molecular epidemiology of pneumococcal carriage and invasive disease Karin Sjöström.
|
|
- Rebecca McKenzie
- 5 years ago
- Views:
Transcription
1 Thesis for doctoral degree (Ph.D.) 2007 Thesis for doctoral degree (Ph.D.) 2007 Molecular epidemiology of pneumococcal carriage and invasive disease Karin Sjöström Molecular Epidemiology of Pneumococcal Carriage and Invasive Disease Karin Sjöström
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38 suggested a low invasive disease potential, i.e. was mainly found in carriage. Isolates could be divided into two groups with one group mainly causing invasive disease, including serotype 1, 4, 7F and 9V, and rarely found among carriers. Serotypes and clones belonging to the second group were found both in invasive disease and among carriers, such as serotype 6B, 14, 6A and 19F where the two latter ones were mainly found among carriers, Figure 4. 24F 31 22F 20 12F 3% 8 4% 1 7% 33F 17F 2 35A 14 12% 7F 8% 18C 16 24F 35B 3% 4% 9N 19A 15B 38 23A 7 3 NT 21 6A 17% 35F 4 12% 9V 7% 6B 5% 11A 15C 9V 10 3% 19F 17% 15C 15B 10C 3 5% 14 7% NT 23A 6A 35F 38 10A 19F 18C 9N 3% 11A 3% 19A 5% 23F 5% 23F 13% 6B 13% Figure 4. Serotype distribution among invasive and carriage isolates. The left circle shows the serotype distribution among the invasive isolates and the right shows the distribution among the carriage isolates. Red colour indicates unique serotypes for respective group. The blue indicates serotypes found among both invasive and carriage isolates. The types causing invasive disease, 1, 4, 7F and 9V, were highly clonally related. All 7F isolates belonged to the same clone and all isolates analysed with MLST revealed the same sequence type, ST191. Among the serotype 1 isolates, the majority were found to belong to the same clonal cluster, with ST228/306 according to MLST analysis. No carriage isolates of serotype 1 were found, and only four (out of 27) carriage isolates of serotype 7F were identified. This is in concordance with a meta analysis of seven different studies by Brueggemann et al where serotype/serogroup 1 and 7 were found to have a high attack rate (Brueggemann et al. 2004). The major clone of serotype 4 belonged to ST205, internationally known as Sweden 4-38, named by the international network on antibiotic resistant pneumococci, PMEN. No type 4 isolate was found among carriers. One clone dominated among type 9V isolates, where four related MLST patterns were found, ST156, ST162, ST1184 and ST1185, all belonging to the same clonal cluster (i.e. differed in less than two out of seven alleles). 27
39 ST156 is an internationally recognised antibiotic resistant clone, PMEN clone Spain 9V - 3 (further discussed in paper IV). Serotype 6B and 14 were found both among invasive and carrier isolates, whereas serotype 6A and 19F were mainly found among carriers, and they all showed a high diversity in conducted molecular analyses. Serotype 19F was the most diverse type compared to all serotypes within the study. A total of 50 serotype 14 isolates were found, out of which 33 were acquired from patients with invasive disease. The major clone within serotype 14 was of ST124, also called Netherlands 14-35, a clone spreading successfully not only in Europe but also in countries on other continents, such as Australia and Canada. Henriques Normark et al observed an increased rate of IPD in Sweden during where this particular clone, seemed to be one major reason for the increase (Henriques Normark et al. 2001). Serotype 6A, 19F and 23F were more commonly found among carriers in our study and serotype 6B and 14 were common in both carriage and IPD, while serotype 3 mainly caused invasive disease. In contrast, serotype 3 was most commonly found causing carriage in the study by Bruggemanns et al (Brueggemann et al. 2004). However, the data from the different studies were, except for this, comparable and came to approximately the same conclusions. In Bruggemanns study the isolates were not characterised to serotype, only to serogroup, and no molecular characterisation was performed. The differences found might be explained by differences in clonal types between the studies, but may also be due to differences in host factors as well as differences in the collection of isolates with respect to geographical areas, ages and time periods studied. In conclusion, Serotype 1, 4, 7F and 9V were mainly found causing invasive disease, while type 6A, 6B, 14 and 19F were mainly found among carriers. Our data suggest that not only the capsular type itself, but also the clonal type is important for the invasive disease potential of pneumococci. Hence, also other bacterial factors than the capsule might be important for disease outcome. 4.2 PAPER II In the second project we aimed to investigate whether there are any correlations between clonal and/or capsular type with clinical characteristics such as age, underlying disease, disease severity and disease type. A total of 494 invasive isolates from adults, 18 years, collected from different parts of the world (Sweden, United States, Canada, 28
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
Benefits of the pneumococcal immunisation programme in children in the United Kingdom
Benefits of the pneumococcal immunisation programme in children in the United Kingdom 2006-2014 Professor Mary P E Slack mpeslack@gmail.com March 2015 Disclosure of interest The presenter has received
More informationPre- and Postvaccination Clonal Compositions of Invasive Pneumococcal Serotypes for Isolates Collected in the United States in 1999, 2001, and 2002
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2006, p. 999 1017 Vol. 44, No. 3 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.3.999 1017.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved.
More informationClinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types
ORIGINAL ARTICLE PULMONARY INFECTIONS Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types Sarah Browall 1,12, Erik Backhaus 2,12, Pontus Naucler 1,3, Ilias Galanis
More informationOutsourcing in Clinical Trials 1-2 July 2015
Outsourcing in Clinical Trials 1-2 July 2015 Innovating Dr Chris Bailey Babraham Research Campus Babraham Cambridge CB22 3AT UK +44 (0)1223 496115 Vaccines www.immbio.com 1 Utilising Academia for the Benefit
More informationInternational Journal of Infectious Diseases
International Journal of Infectious Diseases 14 (2010) e197 e209 Contents lists available at ScienceDirect International Journal of Infectious Diseases journal homepage: www.elsevier.com/locate/ijid Review
More informationReceived 8 February 2006/Returned for modification 17 March 2006/Accepted 27 March 2006
JOURNAL OF CLINICAL MICROBIOLOGY, June 2006, p. 2032 2038 Vol. 44, No. 6 0095-1137/06/$08.00 0 doi:10.1128/jcm.00275-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Distribution
More informationSurveillance of invasive pneumococcal infection in Belgium
Surveillance of invasive pneumococcal infection in Belgium National Reference Laboratory Start in 198 Laboratory Microbiology UH Leuven (prof. J. Vandepitte) Capsular type determination Antibiotic susceptibility
More informationInvasive pneumococcal disease in non-indigenous people in north Queensland,
Invasive pneumococcal disease in non-indigenous people in north Queensland, 2001 2009 Jeffrey N Hanna, Jan L Humphreys, Denise M Murphy and Helen V Smith Although pneumococcal vaccines had been available
More informationChanging epidemiology of Invasive Pneumococcal Disease in the Stockholm area due to the introduction of a 7-valent conjugate vaccine in 2007
Changing epidemiology of Invasive Pneumococcal Disease in the Stockholm area due to the introduction of a 7-valent conjugate vaccine in 2007 Ilias Galanis Masteruppsats i matematisk statistik Master Thesis
More informationNSW Annual Vaccine-Preventable Disease Report, 2011
NSW Annual Vaccine-Preventable Disease Report, 211 Alexander Rosewell A,B, Paula J. Spokes A and Robin E. Gilmour A A Health Protection NSW B Corresponding author. Email: arosw@doh.health.nsw.gov.au Abstract:
More informationEffects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
ORIGINAL ARTICLE RESPIRATORY INFECTIONS Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden Ilias Galanis 1,, Ann Lindstrand 1,2,, Jessica Darenberg 1,, Sarah Browall
More informationIID&GHTP. Pneumococcal vaccine Africa décembre By: Julie Lajoie
IID&GHTP Pneumococcal vaccine Africa décembre 2011 By: Julie Lajoie General information Ecology and Epidemiology of invasive pneumococcal disease (IPD) in sub Saharan Africa is different from that seen
More informationBacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B.
UvA-DARE (Digital Academic Repository) Bacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B. Link to publication Citation for published version (APA): Heckenberg,
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.00869.x Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy I. Serrano, M. Ramirez, the Portuguese Surveillance
More informationTwo-in-one: GSK s candidate PHiD-CV dual pathogen vaccine
Two-in-one: GSK s candidate PHiD-CV dual pathogen vaccine Dr. Bernard Hoet Director, Medical affairs GlaxoSmithKline Biologicals Rixensart, Belgium Istanbul, Feb 13, 2008 PHiD-CV: A novel concept in Bacterial
More informationReceived 7 February 2003/Returned for modification 7 April 2003/Accepted 17 April 2003
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2003, p. 4194 4216 Vol. 41, No. 9 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.9.4194 4216.2003 Clonal Distribution of Invasive Pneumococcal Isolates from Children
More informationImpact of vaccination on epidemiology in adults
Impact of vaccination on epidemiology in adults Jan Verhaegen 1. Data on prospective study on IPD in Belgium (2009-2011) 2. Evolution of capsular types of invasive isolates from adults after introduction
More informationBacterial meningitis: epidemiology, herd protection, clinical characteristics, and risk assessment Bijlsma, M.W.
UvA-DARE (Digital Academic Repository) Bacterial meningitis: epidemiology, herd protection, clinical characteristics, and risk assessment Bijlsma, M.W. Link to publication Citation for published version
More informationHans Jürgen Dornbusch
Epidemiology of Invasive Meningococcal Disease Hans Jürgen Dornbusch Infectious Vaccination Disease Working Working Group Group Severe bacterial infections Pneumococcus Haemophilus influenzae b 3 rd World!
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/49864
More informationMulti-drug Resistant Serotype 19A Pneumococci in Toronto
TML Lab Rounds January 17, 2008 Multi-drug Resistant Serotype 19A Pneumococci in Toronto The Role of the Microbiology Lab Susan M. Poutanen, MD, MPH, FRCPC Microbiologist/ID Consultant, TML/MSH Assistant
More informationPneumococcal vaccination for older persons. No. 2018/05. Executive summary
Pneumococcal vaccination for older persons No. 2018/05 Executive summary Executive summary Pneumococcal vaccination for older persons page 2 of 6 Many people carry pneumococcal bacteria without becoming
More informationExpanded Use of PCV13 & PPV23
Expanded Use of PCV13 & PPV23 Dr. Jim Kellner Professor & Head Department of Pediatrics University of Calgary & Calgary Zone, Alberta Health Services Jim.Kellner@ahs.ca Objectives Explain the differences
More informationAbility of Pneumococcal Serotypes and Clones To Cause Acute Otitis Media: Implications for the Prevention of Otitis Media by Conjugate Vaccines
INFECTION AND IMMUNITY, Jan. 2004, p. 76 81 Vol. 72, No. 1 0019-9567/04/$08.00 0 DOI: 10.1128/IAI.72.1.76 81.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Ability of Pneumococcal
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationDiagnosis of Pneumococcal Disease
Diagnosis of Pneumococcal Disease Limitations of Surveillance for Invasive Disease David Murdoch University of Otago, Christchurch New Zealand Key Points We are still reliant on culture-based methods for
More informationBacterial diseases caused by Streptoccus pneumoniae in children
Bacterial diseases caused by Streptoccus pneumoniae in children Bactermia 85% Bacterial pneumonia 66% Bacterial meningitis 50% Otitis media 40% Paranasal sinusitis 40% 0% 10% 20% 30% 40% 50% 60% 70% 80%
More informationEARSS in Ireland, Results of invasive Streptococcus pneumoniae infection (blood/csf) surveillance
EARSS in Ireland, 2007 Results of invasive Streptococcus pneumoniae infection (blood/csf) surveillance Antibiotic codes and abbreviations: CTX, Ciprofloxacin ERY, Erythromycin OXA, Oxacillin TCY, Tetracycline
More informationReceived 31 July 2009/Returned for modification 12 October 2009/Accepted 10 November 2009
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2010, p. 87 96 Vol. 48, No. 1 0095-1137/10/$12.00 doi:10.1128/jcm.01485-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Temporal Analysis
More informationFrom DEPARTMENT OF PUBLIC HEALTH SCIENCES Karolinska Institutet, Stockholm, Sweden
From DEPARTMENT OF PUBLIC HEALTH SCIENCES Karolinska Institutet, Stockholm, Sweden Impact of Pneumococcal Conjugate Vaccine on Pneumococcal Disease, Carriage and Serotype Distribution Comparative studies
More informationAntibiotic-Resistant Invasive Pneumococcal Clones in Italy
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2007, p. 306 312 Vol. 45, No. 2 0095-1137/07/$08.00 0 doi:10.1128/jcm.01229-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Antibiotic-Resistant
More informationVaccines. Robert Read University of Southampton University Hospital Southampton
Vaccines Robert Read University of Southampton University Hospital Southampton Disclosures Non personal, non specific; Novartis-GSK Member, JCVI Editor in Chief, Journal of Infection, and Current Opinion
More informationMolecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions ( )
DOI 10.1007/s10096-011-1399-3 ARTICLE Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994 2009) J. M. Marimón & M. Alonso & D.
More informationPr Robert Cohen CHI Créteil France
EFFECT OF VACCINATION ON ANTIMICROBIAL RESISTANCE : THE EXAMPLE OF THE IMPACT OF PCVS ON ANTIBIOTIC RESISTANCE Pr Robert Cohen CHI Créteil France 1 DISCLOSURES I have received during the las 3 years honorarium
More informationAntimicrobial susceptibility, carriage, children, day-care centres, orphanages, Streptococcus pneumoniae
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01505.x Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre
More informationInvasive meningococal diseasefocus on Meningococcal B - epidemiology, international and Ireland
Invasive meningococal diseasefocus on Meningococcal B - epidemiology, international and Ireland Dr Suzanne Cotter, Health Protection Surveillance Centre (HPSC) Scope presentation Meningococccal disease
More informationTransmission of Streptococcus pneumoniae in Rural Gambian Villages: A Longitudinal Study
MAJOR ARTICLE Transmission of Streptococcus pneumoniae in Rural Gambian Villages: A Longitudinal Study Philip C. Hill, 1,2 John Townend, 1 Martin Antonio, 1 Biodun Akisanya, 1 Chinelo Ebruke, 1 George
More informationDissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(b) and mef(a) in South Korea
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2003, p. 5787 5791 Vol. 41, No. 12 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.12.5787 5791.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationFrom Sticky Mucus to Probing our Past: Aspects and problems of the Biotechnological use of Macromolecules
From Sticky Mucus to Probing our Past: Aspects and problems of the Biotechnological use of Macromolecules Carbohydrate Vaccines Macromolecules as Vaccines Steve Harding Vaccination Vaccine produces immunity
More informationIncreased incidence of invasive group A streptococcal infections in Sweden, January 2012 February 2013
Rapid communications Increased incidence of invasive group A streptococcal infections in Sweden, uary 12 February 13 J Darenberg (Jessica.Darenberg@smi.se) 1, B Henriques-Normark 1,2,3, T Lepp 1, K Tegmark-Wisell
More informationAlberta Health and Wellness Public Health Notifiable Disease Management Guidelines August Pneumococcal Disease, Invasive (IPD)
August 2011 Pneumococcal Disease, Invasive (IPD) Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) Case Definition August
More informationIncreasing Genetic Relatedness of Ciprofloxacin-Resistant Streptococcus pneumoniae Isolated in Canada from 1997 to 2005
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 2008, p. 1190 1194 Vol. 52, No. 3 0066-4804/08/$08.00 0 doi:10.1128/aac.01260-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Increasing
More informationPneumococcal vaccines. Safety & Efficacy. Prof. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh
Pneumococcal vaccines Safety & Efficacy Prof. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh Disclosure Slide X X I DO NOT have any significant or other financial relationships with industry
More informationCraig Laferriere. The selection of pneumococcal serotypes for a developing-world vaccine: A metaregression analysis of immunogenicity
Craig Laferriere The selection of pneumococcal serotypes for a developing-world vaccine: A metaregression analysis of immunogenicity I have no actual or potential conflict of interest in relation to this
More informationNeisseria meningitidis; clones, carriage, and disease
REVIEW 10.1111/1469-0691.12647 Neisseria meningitidis; clones, carriage, and disease R. C. Read Clinical and Experimental Sciences and NIHR Respiratory Biomedical Research Unit, Faculty of Medicine, University
More informationStreptococcus pneumoniae: serotype diversity and epidemiology Dr Bambos Charalambous
Streptococcus pneumoniae: Serotype Diversity and Epidemiology 1 Senior Lecturer in Clinical Microbiology University College London, UK Overview Capsule, serotype and antigenicity Global serotype distribution:
More informationReport of Typing & Antimicrobial Susceptibilities of Isolates Causing Invasive Pneumococcal Disease in Ireland,
Report of Typing & Antimicrobial Susceptibilities of Isolates Causing Invasive Pneumococcal Disease in Ireland, 2011-2013 1. Background Streptococcus pneumoniae is a major cause of life-threatening infections
More informationPneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections
Pneumococcal vaccination in UK: an update Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections Leading infectious causes of mortality, 2000 WHO estimates 3.5 Deaths
More informationCarga global de la enfermedad neumocócia
Carga global de la enfermedad neumocócia Ann R. Thomas, MD MPH Public Health Division Portland, Oregon Caracas, Venezuela, January 2008 Acknowledgements to Adam Cohen, CDC Principales Causas de Muertes
More informationAssociation of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta-Analysis
MAJOR ARTICLE Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta-Analysis Daniel M. Weinberger, 1 Zitta B. Harboe, 6,7 Elisabeth A. M. Sanders, 8 Moses Ndiritu, 10 Keith P.
More informationSerogroup W in Africa & travellers
Serogroup W in Africa & travellers Muhamed-Kheir TAHA Institut Pasteur 01/11/2016 2 childhood meningococcal meningitis caused by this serogroup. Three infants, two with bacteremia and one with septic arthritis
More informationSerotyping pneumococcal meningitis cases in the African meningitis belt using multiplex. PCR on cerebrospinal fluid
JCM Accepts, published online ahead of print on 9 December 2009 J. Clin. Microbiol. doi:10.1128/jcm.01402-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationPneumococcal disease: Global burden, epidemiology, scope for vaccine prevention
Pneumococcal disease: Global burden, epidemiology, scope for vaccine prevention Stephanie Schrag Centers for Disease Control and Prevention Atlanta, GA San Jose, Costa Rica, August 2007 Pneumococcal Carriage
More informationCarga global de la enfermedad neumocócia Adam L. Cohen, MD MPH Centers for Disease Control and Prevention Atlanta, GA
Carga global de la enfermedad neumocócia Adam L. Cohen, MD MPH Centers for Disease Control and Prevention Atlanta, GA Santiago, Chile, December 2007 Pneumococcal Carriage and Disease Ear infections Meningitis
More informationGenetic structures of invasive Streptococcus pneumoniae isolates from Korean children obtained between 1995 and 2013
Yun et al. BMC Infectious Diseases (2018) 18:268 https://doi.org/10.1186/s12879-018-3177-7 RESEARCH ARTICLE Open Access Genetic structures of invasive Streptococcus pneumoniae isolates from Korean children
More information...REPORTS... Epidemiology of Pneumococcal Disease/ Rationale for and Efficacy of PnC7
...REPORTS... Epidemiology of Pneumococcal Disease/ Rationale for and Efficacy of PnC7 Summary A Streptococcus pneumoniae Conjugate Vaccine Managed Care Advisory Panel was presented with information on
More informationINVASIVE NEISSERIA MENINGITIDIS IN EUROPE 2001
COMMISSION OF THE EUROPEAN COMMUNITIES Programme on Community action on the prevention of AIDS and certain other communicable diseases DG SANCO Agreement No. VS/1999/3504 (99CVF4-031) INVASIVE NEISSERIA
More informationINVASIVE NEISSERIA MENINGITIDIS IN EUROPE 2002
COMMISSION OF THE EUROPEAN COMMUNITIES Programme on Community action on the prevention of AIDS and certain other communicable diseases DG SANCO Agreement No. VS/1999/3504 (99CVF4-031) INVASIVE NEISSERIA
More informationPneumococcal pneumonia
Pneumococcal pneumonia Wei Shen Lim Consultant Respiratory Physician & Honorary Professor of Medicine Nottingham University Hospitals NHS Trust University of Nottingham Declarations of interest Unrestricted
More informationMolecular Characterization of Non-Penicillin-Susceptible Streptococcus pneumoniae in Norway
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2006, p. 3225 3230 Vol. 44, No. 9 0095-1137/06/$08.00 0 doi:10.1128/jcm.00524-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Molecular
More informationPopulation Snapshot of Streptococcus pneumoniae Causing Invasive Disease in South Africa Prior to Introduction of Pneumococcal Conjugate Vaccines
Population Snapshot of Streptococcus pneumoniae Causing Invasive Disease in South Africa Prior to Introduction of Pneumococcal Conjugate Vaccines Kedibone M. Ndlangisa, National Institute for Communicable
More informationEpidemiology of Invasive Pneumococcal Disease in Older People in Spain ( ): Implications for Future Vaccination Strategies
Epidemiology of Invasive Pneumococcal Disease in Older People in Spain (2007 2009): Implications for Future Vaccination Strategies Carmen Ardanuy 1,2 *, José María Marimón 2,3, Laura Calatayud 1,2, Montserrat
More informationViral Agents of Paediatric Gastroenteritis
Viral Agents of Paediatric Gastroenteritis Dr Carl Kirkwood -------------------- Enteric Virus Research Group Murdoch Childrens Research Institute Royal Children s Hospital Victoria. WHO Collaborating
More informationDownloaded from:
Donkor, ES; Adegbola, RA; Wren, BW; Antonio, M (2013) Population Biology of Streptococcus pneumoniae in West Africa: Multilocus Sequence Typing of Serotypes That Exhibit Different Predisposition to Invasive
More informationPneumococcal Vaccine Introductions Dr. Carsten Mantel WHO/FCH/IVB/EPI
Pneumococcal Vaccine Introductions 2012 Dr. Carsten Mantel WHO/FCH/IVB/EPI Pneumonia is leading cause of death in children < 5 yrs * Pneumococcus and Hib are the two leading causes of life-threatening
More informationPneumococcal Vaccines. What s right for your clients?
Pneumococcal Vaccines What s right for your clients? Vaccines Available - Pneumovax 23 A pneumococcal polysaccharide vaccine that includes 23 purified capsular polysaccharide antigens Vaccines Available
More informationBiology of Neisseria meningitidis: implications for vaccine development Richard Moxon: University of Oxford
Biology of Neisseria meningitidis: implications for vaccine development Richard Moxon: University of Oxford Biology of N.meningitidis infection Within hours, the disease may progress to shock with multi-organ
More informationAppendix B: Provincial Case Definitions for Reportable Diseases
Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Pneumococcal disease, invasive Revised December 2014 Pneumococcal disease, invasive 1.0 Provincial
More informationACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults
ACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults National Center for Immunization & Respiratory Diseases Respiratory Diseases Branch ACIP
More informationÖrebro University Hospital
Örebro University Hospital Department of Laboratory Medicine Susanne Jacobsson Date: 2015-02-18 Page 1 (8) Neisseria meningitidis 2014 Annual report concerning serogroup, genosubtype and antibiotic susceptibility
More informationPneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes
1 Infectious Disease Department of Hospital Universitari de Bellvitge, Institut d Investigació Biomèdica de Bellvitge (IDIBELL), Spanish Network for the Research in Infectious Diseases (REIPI), University
More informationPneumococcal Vaccine Effectiveness. Steven Black, MD Center for Global Health Cincinnati Children s s Hospital Cincinnati, Ohio USA
Pneumococcal Vaccine Effectiveness Steven Black, MD Center for Global Health Cincinnati Children s s Hospital Cincinnati, Ohio USA Overview Possible effectiveness outcomes for pneumococcal vaccines Pre-licensure
More informationStreptococcus suis: struggling against disease
Streptococcus suis: struggling against disease Marcelo Gottschalk, DVM, PhD Faculty of Veterinary Medicine University of Montreal, Canada Number of publications on S. suis throughout the years Streptococcus
More informationMonitoring vaccine-preventable diseases is
New South Wales annual vaccinepreventable disease report, 2013 Surveillance Report Alexander Rosewell, a Paula Spokes a and Robin Gilmour a Correspondence to Robin Gilmour (e-mail: rgilm@doh.health.nsw.gov.au).
More informationMulticomponent MenB Vaccine (4CMenB): An Innovative Step In the Global Fight Against Serogroup B Meningococcal Disease
Multicomponent MenB Vaccine (4CMenB): An Innovative Step In the Global Fight Against Serogroup B Meningococcal Disease Jeffrey J. Stoddard, MD, FAAP Head, Global Medical Affairs Novartis Vaccines and Diagnostics
More informationPROFESSOR PETER M. HAWKEY
Multi-drug resistant Escherichia coli PROFESSOR PETER M. HAWKEY School of Immunity and Infection College of Medical and Dental Sciences University of Birmingham Birmingham B15 2TT Health Protection Agency
More informationStreptococcus pneumoniae
Streptococcus pneumoniae EPIDEMIOLOGY AND PREVENTION 2^4. November 2007 Prof. Dr. Kathrin Mühlemann Klinik und Poliklinik für Infektionskrankheiten Universität Bern, INSELSPITAL S. pneumoniae: epidemiology
More informationImpacto de la vacuna conjugada en EUA
Impacto de la vacuna conjugada en EUA Richard Facklam, PhD, Distinguished Consultant, Retired, Centers for Disease Control and Prevention Atlanta, GA Bogotá, Colombia, February 2008 Pneumococcal Conjugate
More informationInvasive Pneumococcal Infections
Invasive Pneumococcal Infections Erik Backhaus Department of Infectious Diseases, Institute of Biomedicine Sahlgrenska Academy University of Gothenburg Sweden 2012 ISBN 978-91-628-8392-8 http://hdl.handle.net/2077/27821
More informationPotential Impact of Conjugate Vaccine on the Incidence of Invasive Pneumococcal Disease among Children in Scotland
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2006, p. 1224 1228 Vol. 44, No. 4 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.4.1224 1228.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved.
More informationSURVEILLANCE REPORT. Surveillance of invasive bacterial diseases in Europe.
SURVEILLANCE REPORT Surveillance of invasive bacterial diseases in Europe 2007 www.ecdc.europa.eu ECDC SURVEILLANCE REPORT Surveillance of invasive bacterial diseases in Europe 2007 Suggested citation:
More informationCUMULATIVE INVASIVE PNEUMOCOCCAL DISEASE CASE NUMBERS REPORTED BY THE GERMS-SA SURVEILLANCE PROGRAMME, 2005 TO DATE
CUMULATIVE INVASIVE PNEUMOCOCCAL DISEASE CASE NUMBERS REPORTED BY THE GERMS-SA SURVEILLANCE PROGRAMME, 5 TO DATE GERMS-SA surveillance programme http://www.nicd.ac.za/?page=germs-sa&id=97 National, active,
More informationInfections caused by Streptococcus pneumoniae are common worldwide
DOI 10. 5001/omj.2011.11 Serotype Prevalence and Penicillin-susceptibility of Streptococcus pneumoniae in Oman Mubarak M. Al-Yaqoubi, 1 Kamal M. Elhag 2 Received: 24 Sept 2010 / Accepted: 23 Dec 2010 OMSB,
More information4-6 Inheritance Biology
4-6 Inheritance Biology.0 Figure shows a cell from the small intestine. Figure. Which part of the cell contains chromosomes? Circle one part from the list. Cell membrane Cytoplasm Nucleus Mitochondria.2
More informationEffect of Introduction of Pneumococcal Conjugate Vaccine Immunization on. Nasopharyngeal Colonization of Streptococcus pneumoniae in South Africa
Effect of Introduction of Pneumococcal Conjugate Vaccine Immunization on Nasopharyngeal Colonization of Streptococcus pneumoniae in South Africa Susan Audrey Nzenze 464223 A thesis submitted to the Faculty
More informationMeningitis January Dr Andrew Lee Consultant in Communicable Disease Control, PHE Information in this slide set was correct as of 21.1.
Meningitis January 2016 Dr Andrew Lee Consultant in Communicable Disease Control, PHE Information in this slide set was correct as of 21.1.16 Outline What is meningitis What causes it What are the signs
More informationWorld Health Organization Department of Communicable Disease Surveillance and Response
WHO/CDS/CSR/DRS/2001.6 Resistant pneumococcal infections Stephanie J. Schrag, Bernard Beall and Scott Dowell World Health Organization Department of Communicable Disease Surveillance and Response This
More informationPneumoccocal vaccines in the elderly (conjugated vs polysaccharides)
Aging and Immunity II Campus Novartis, Siena April 24, 2012 Pneumoccocal vaccines in the elderly (conjugated vs polysaccharides) Paolo Bonanni Department of Public Health University of Florence, Italy
More informationINVASIVE NEISSERIA MENINGITIDIS IN EUROPE 2003/2004
COMMISSION OF THE EUROPEAN COMMUNITIES Programme on Community action on the prevention of AIDS and certain other communicable diseases DG SANCO Agreement No 2003202 EU-IBIS INVASIVE NEISSERIA MENINGITIDIS
More informationTitle: Cost-Effectiveness of 2+1 Dosing of 13-Valent and 10-Valent Pneumococcal Conjugate Vaccines in Canada
Author's response to reviews Title: Cost-Effectiveness of 2+1 Dosing of 13-Valent and 10-Valent Pneumococcal Conjugate Vaccines in Canada Authors: Stephanie R Earnshaw (searnshaw@rti.org) Cheryl L McDade
More informationEPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002
EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002 Robyn Gilmour Communicable Diseases Branch NSW Department of Health BACKGROUND Infection with the bacterium Streptococcus pneumoniae is a major cause
More informationX THIS SUMMARY DOES NOT INCLUDE ! THIS SUMMARY INCLUDES
OPTIMIZING PNEUMOCOCCAL CONJUGATE VACCINES (PCV) SCHEDULES FOR CHILDREN IN VARIOUS AREAS OF THE WORLD What is the relative effect of administering PCV vaccines using a 3 primary doses (3p) versus 2 primary
More informationImpact of meningococcal C conjugate vaccine in the UK
J. Med. Microbiol. Vol. 51 (22), 717 722 # 22 Society for General Microbiology ISSN 22-2615 REVIEW ARTICLE Impact of meningococcal C conjugate vaccine in the UK P. BALMER, R. BORROW and E. MILLER Meningococcal
More information9/12/2018. Pneumococcal Disease and Pneumococcal Vaccines. Streptococcus pneumoniae. Pneumococcal Disease. Adult Track. Gram-positive bacteria
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Pneumococcal Disease and Pneumococcal Vaccines Adult Track Chapter 17 Photographs and images included
More informationWhy is surveillance important after introducing vaccines?
Why is surveillance important after introducing vaccines? Dr Michael Edelstein Immunisation Department, National Infections service Public Health England @epi_michael BSAC Spring conference, 12 th March
More informationPNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID
PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID Objectives of Lecture Know the quality of current evidence based guidelines on immunization Appreciate the performance of pneumonia vaccines in terns
More informationSurveillance of Enterococci in Belgium. M. Ieven, K. Loens, B. Jans and H. Goossens
Surveillance of Enterococci in Belgium M. Ieven, K. Loens, B. Jans and H. Goossens Surveillance of Enterococci in Belgium Overview Introduction and epidemiological surveillance Results of isolates received
More informationAffiliation address: Laboratoire d épidémiologie moléculaire, Institut Pasteur de Nouvelle-
JCM Accepts, published online ahead of print on June 00 J. Clin. Microbiol. doi:0./jcm.0-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. 0
More informationThe Official Journal of the Kettil Bruun Society for Social and Epidemiological Research on Alcohol
IJADR International Journal of Alcohol and Drug Research The Official Journal of the Kettil Bruun Society for Social and Epidemiological Research on Alcohol doi: 10.7895/ijadr.v1i1.44 IJADR, 2012, 1(1),
More information